BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Feb 07, 2011
 |  BC Week In Review  |  Company News  |  Deals

Genzyme, International Chemical Investors Group deal

International Chemical will acquire Genzyme's pharmaceutical intermediates business, excluding the drug delivery technologies portion, for an undisclosed amount. The unit develops and manufactures chemically synthesized pharmaceutical materials and technologies and focuses on lipids, peptides, carbohydrates, oligonucleotides and custom small molecules....

Read the full 176 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >